Dr Reddy’s profit up 91% to Rs.4,507 cr in FY23
Dr Reddy’s Laboratories Ltd reported 91 per cent year-on-year rise in profit after tax (PAT) to Rs 4,507 crore in FY 2022-23.
Dr Reddy’s posts healthy Q1 net on Russian biz dose
Hyderabad: Dr Reddy’s Laboratories Ltd reported 91 per cent year-on-year rise in profit after tax (PAT) to Rs 4,507 crore in FY 2022-23. Its revenue has surged up 15 per cent y-o-y to Rs 24,588 crore in the last fiscal.
The company has registered 996 per cent y-o-y growth in PAT at Rs 959 crore and 16 per cent y-o-y increase in revenue at Rs 6,297 crore during the fourth quarter of FY23.Commenting on the results, G V Prasad, Co-Chairman & MD of Dr Reddy’s, said: “FY23 has been a year of record sales, profits and cash flow, driven by our performance in US Generics.
We progressed well in our productivity and sustainability agenda. We will continue to deliver on our purpose, invest in growth drivers and promote a culture that is innovative and collaborative ensuring the future of our business.”
